Tokyo Tape
Sign in
← AuBEX

Quarterly report · Q1

3583.TEDINET S100OWKG
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 31
MetricValuePeriodScopeSource row
Revenue¥1.3bn2022-04-01 → 2022-06-30Cons.Net sales
Revenue¥5.5bn2021-04-01 → 2022-03-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2021-04-01 → 2021-06-30Cons.Net sales
Operating income¥154m2022-04-01 → 2022-06-30Cons.Operating income
Operating income¥148m2021-04-01 → 2021-06-30Cons.Operating income
Ordinary income¥178m2022-04-01 → 2022-06-30Cons.Ordinary income
Ordinary income¥727m2021-04-01 → 2022-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥150m2021-04-01 → 2021-06-30Cons.Ordinary income
Profit before tax¥231m2022-04-01 → 2022-06-30Cons.Income before income taxes
Profit before tax¥150m2021-04-01 → 2021-06-30Cons.Income before income taxes
Net income (owners)¥161m2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥537m2021-04-01 → 2022-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥104m2021-04-01 → 2021-06-30Cons.Profit loss attributable to owners of parent
Net income¥161m2022-04-01 → 2022-06-30Cons.Profit loss
Net income¥104m2021-04-01 → 2021-06-30Cons.Profit loss
Total assets¥9.5bnat 2022-06-30Cons.Assets
Total assets¥9.4bnat 2022-03-31Cons.Assets
Total assets¥8.8bnat 2021-06-30Cons.Total assets (5-year summary)
Total liabilities¥4.0bnat 2022-06-30Cons.Liabilities
Total liabilities¥4.0bnat 2022-03-31Cons.Liabilities
Net assets / equity¥5.5bnat 2022-06-30Cons.Net assets
Net assets / equity¥5.4bnat 2022-03-31Cons.Net assets
Net assets / equity¥4.9bnat 2021-06-30Cons.Net assets (5-year summary)
Cash and deposits¥2.6bnat 2022-06-30Cons.Cash and deposits
Cash and deposits¥2.5bnat 2022-03-31Cons.Cash and deposits
EPS (basic)¥58.322022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥194.042021-04-01 → 2022-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥37.482021-04-01 → 2021-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio57.9%at 2022-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio57.4%at 2022-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio55.4%at 2021-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 37
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-06-30¥221,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-06-30¥6m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-06-30−¥3m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥353m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥352m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥1m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥25m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue2022-04-01 → 2022-06-30¥981m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue external2022-04-01 → 2022-06-30¥981m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentsegment profit2022-04-01 → 2022-06-30¥205m
—segment totalrevenue2022-04-01 → 2022-06-30¥1.3bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥1.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥1m
—segment totalsegment profit2022-04-01 → 2022-06-30¥230m
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-06-30¥7m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-06-30¥227m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2021-04-01 → 2021-06-30¥822,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2021-04-01 → 2021-06-30¥822,000
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2021-04-01 → 2021-06-30−¥5m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue2021-04-01 → 2021-06-30¥329m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue external2021-04-01 → 2021-06-30¥328m
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentrevenue intersegment2021-04-01 → 2021-06-30¥891,000
jpcrp040300-q1r_E00584-000Medical Productsreportable segmentsegment profit2021-04-01 → 2021-06-30¥36m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue2021-04-01 → 2021-06-30¥973m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentrevenue external2021-04-01 → 2021-06-30¥973m
jpcrp040300-q1r_E00584-000Technological Productsreportable segmentsegment profit2021-04-01 → 2021-06-30¥190m
—segment totalrevenue2021-04-01 → 2021-06-30¥1.3bn
—segment totalrevenue external2021-04-01 → 2021-06-30¥1.3bn
—segment totalrevenue intersegment2021-04-01 → 2021-06-30¥891,000
—segment totalsegment profit2021-04-01 → 2021-06-30¥226m
Total Of Reportable Segments And Otherssegment totalrevenue2021-04-01 → 2021-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-04-01 → 2021-06-30¥1.3bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2021-04-01 → 2021-06-30¥891,000
Total Of Reportable Segments And Otherssegment totalsegment profit2021-04-01 → 2021-06-30¥220m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 373
ItemContextValueUnit
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember973205000JPY
Net salesPrior1YTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember328838000JPY
Net salesPrior1YTDDuration_ReportableSegmentsMember1302044000JPY
Net salesPrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember822000JPY
Net salesPrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember1302866000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember189567000JPY
Operating incomePrior1YTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember36087000JPY
Operating incomePrior1YTDDuration_ReportableSegmentsMember225654000JPY
Operating incomePrior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-5411000JPY
Operating incomePrior1YTDDuration_TotalOfReportableSegmentsAndOthersMember220242000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember980937000JPY
Revenues from external customersCurrentYTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember351851000JPY
Revenues from external customersCurrentYTDDuration_ReportableSegmentsMember1332789000JPY
Revenues from external customersCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember221000JPY
Revenues from external customersCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1333010000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember－JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember1099000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember1099000JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember6000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember7099000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember980937000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember352950000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember1333888000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember6221000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember1340109000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00584-000TechnologicalProductsReportableSegmentsMember205035000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00584-000MedicalProductsReportableSegmentsMember25190000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember230225000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-2896000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember227328000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2022-08-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第138期第１四半期(自 2022年４月１日 至 2022年６月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)オーベクス株式会社
Company name in english cover pageFilingDateInstantAuBEX CORPORATION
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長 栗 原 則 義
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都墨田区両国四丁目31番11号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03(6701)3200(代表)
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役管理部長 塚 越 孝 弘
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都墨田区両国四丁目31番11号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03(6701)3200(代表)
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役管理部長 塚 越 孝 弘
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00584
Fund codeFilingDateInstant－
Security codeFilingDateInstant35830
Filer name in japaneseFilingDateInstant
Original text (Japanese)オーベクス株式会社
Filer name in englishFilingDateInstantAuBEX CORPORATION

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-03-31pass rounding
balance sheet identityconsolidated 2022-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-03-31pass
statement vs summary · net assetsconsolidated 2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2021-04-01/2021-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2021-04-01/2021-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · total assetsconsolidated 2022-03-31pass
statement vs summary · total assetsconsolidated 2022-06-30pass